WB 1:500-2000; IHC 1:50-200 / Note: For IHC, we suggest antigen retrieval with TE buffer pH 9.0 (Cat#YS0004)
Formulation
Liquid in PBS containing 50% glycerol,0.5% BSA and 0.02% sodium azide.
Source
Purification
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Purity
Storage
-15°C to -25°C/1 year(Do not lower than -25°C)
Concentration
1 mg/ml
Clonality
Polyclonal
Clone Number
Immunogen
Synthesized peptide derived from human N-ternal TXNIP
Sequence
Specificity
This antibody detects endogenous levels of TXNIP at Human, Mouse,Rat
Gene Name
TXNIP VDUP1
Protein Name
Thioredoxin-interacting protein (Thioredoxin-binding protein 2) (Vitamin D3 up-regulated protein 1)
Other Name
Thioredoxin-interacting protein; / Thioredoxin-binding protein 2; / Vitamin D3 up-regulated protein 1
Species
Human
Gene ID-1
10628
Uniprot
Q9H3M7,
Species.1
Mouse
Gene ID-2
56338
Uniprot.1
Q8BG60,
Species.2
Rat
Gene ID-3
117514
Uniprot.2
Q5M7W1
Organism-4
Gene ID-4
SwissProt-4
Background
Cellular Localization
Cytoplasm .
Tissue Expression
Signaling_pathway
Organismal Systems >> Immune system >> NOD-like receptor signaling pathway
Research Areas
Function
May act as an oxidative stress mediator by inhibiting thioredoxin activity or by limiting its bioavailability. Interacts with COPS5 and restores COPS5-induced suppression of CDKN1B stability, blocking the COPS5-mediated translocation of CDKN1B from the nucleus to the cytoplasm. Functions as a transcriptional repressor, possibly by acting as a bridge molecule between transcription factors and corepressor complexes, and over-expression will induce G0/G1 cell cycle arrest. Required for the maturation of natural killer cells. Acts as a suppressor of tumor cell growth. Inhibits the proteasomal degradation of DDIT4, and thereby contributes to the inhibition of the mammalian target of rapamycin complex 1 (mTORC1).